Combining deep sector knowledge and expertise with a tireless work ethic, I am extremely motivated by helping my clients achieve world class outcomes.
Ray provides mergers and acquisitions (M&A) advisory to global clients across the entire healthcare spectrum. He has extensive experience in sell-side and buy-side transactions, as well as other strategic advisory engagements, and has completed numerous transactions with leading private equity groups and privately-held companies, including founder/family-owned businesses.
Ray has a lifelong passion for healthcare that fuels his work for helping his clients achieve successful outcomes that benefit not only his clients, but also the greater healthcare sector and community as a whole. He takes great pride in earning the trust and confidence of his clients, and forging long-term relationships based on collaboration, and honest, thoughtful advice.
Prior to joining Lincoln as an Associate, Ray worked as an investment banker at Kaufman Hall & Associates, where he focused solely on the healthcare industry. Previously, Ray worked in the Valuation Advisory practice at Stout Risius Ross and as a Certified Public Accountant (CPA) at PricewaterhouseCoopers where he began his career.
Ray earned a Master of Accounting and a Bachelor of Business Administration from the University of Michigan, Ross School of Business.
Recent Transactions in Healthcare
Lincoln International is pleased to announce that it served as the exclusive financial advisor to Alva-Amco Pharmacal in its sale to Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)
Lincoln International is pleased to announce that Choice Health Insurance, LLC, a fully integrated consumer acquisition platform specializing in the high-growth, Medicare Advantage marketplace, has been acquired by Alight Solutions, a portfolio company of Blackstone
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack
Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ) has received an investment from Abry Partners LP
Lincoln International advised Gruppo Sapio on the acquisition of a majority stake in Homeperf from Parquest Capital; BNP Paribas Développement and Arkea Capital will reinvest in the business alongside Sapio
Lincoln International is pleased to announce that it has advised IntegriChain, Inc. on the acquisition of the life sciences division of Cumberland
Lincoln International is pleased to announce the sale of substantially all of the operating assets of Valeritas Holdings, Inc. (NASDAQ:VLRX) pursuant to Section 363 of the U.S. Bankruptcy Code to Zealand Pharma A/S (NASDAQ:ZEAL)